The drug Amoksiklav 625 belongs to the group of antibiotics known as penicillin combinations. It is a broad-spectrum antibiotic that is effective against many different types of bacteria. Amoksiklav 625 is made up of two drugs: Amoxicillin (the active ingredient of antibiotics) and Clavulanic acid (which increases the effectiveness of amoxicillin).

Vitabactam is a combination of two drugs, Cefoperazone and Sulbactam. In particular, the ingredient cefoperazone is an antibiotic, which works by preventing the formation of a protective bacterial coating that is necessary for the survival of bacteria. At the same time, sulbactam is a representative of beta-lactamase inhibitors, synergistically reducing resistance, thus enhancing the activity of Cefoperazone against bacteria. As a result, vitabactam is useful in the treatment of moderate to severe infections in many organ systems.